Eurazeo 관리

관리 기준 확인 2/4

Eurazeo CEO는 Christophe Baviere, Mar2021 에 임명되었습니다 의 임기는 3.67 년입니다. 는 € 11.28M 가치에 해당하는 회사 주식의 0.22% 직접 소유합니다. 11.28M. 경영진과 이사회의 평균 재임 기간은 각각 2.7 년과 10.5 년입니다.

주요 정보

Christophe Baviere

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	3.7yrs
CEO 소유권	0.2%
경영진 평균 재임 기간	2.7yrs
이사회 평균 재임 기간	10.5yrs

최근 관리 업데이트

What Can We Make Of Eurazeo's (EPA:RF) CEO Compensation?

Dec 18

Recent updates

CEO 보상 분석

Christophe Baviere 의 보수는 Eurazeo 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Jun 30 2024	n/a	n/a	-€77m
Mar 31 2024	n/a	n/a	€873m
Dec 31 2023	n/a	n/a	€2b
Sep 30 2023	n/a	n/a	€2b
Jun 30 2023	n/a	n/a	€2b
Mar 31 2023	n/a	n/a	€2b
Dec 31 2022	€2m	€555k	€595m
Sep 30 2022	n/a	n/a	€801m
Jun 30 2022	n/a	n/a	€1b
Mar 31 2022	n/a	n/a	€1b
Dec 31 2021	€1m	€487k	€2b

보상 대 시장: French 시장에서 비슷한 규모의 회사에 비해 Christophe 의 총 보상이 합리적인지 여부를 입증하기에는 데이터가 부족합니다.

보상과 수익: 회사가 수익성이 없는 동안 Christophe 의 보상이 증가했습니다.

CEO

Christophe Baviere (60 yo)

3.7yrs

테뉴어

€1,791,427

보상

Mr. Christophe M. Baviere serves as Co-Chief Executive Officer at Eurazeo North America, Inc since February 2023. He is Co-Chairman of the Executive Board & Co-CEO of Eurazeo SE from 2023. He was Chairman...

리더십 팀

이름	위치	테뉴어	보상	소유권
Christophe Baviere	Co-CEO & Co-Chairman of the Executive Board	3.7yrs	€1.79m	0.22% € 11.3m
William Kadouch-Chassaing	Co-CEO & Co-Chairman of Executive Board	2.7yrs	€1.68m	데이터 없음
Olivier Millet	Member of the Executive Board and Managing Partner of Small-mid buyout & NovSanté	6.7yrs	€1.62m	0.071% € 3.6m
Laurence Branthomme	CFO & Head of Operations	1.8yrs	데이터 없음	데이터 없음
Sophie Flak	Member of Executive Board and Managing Partner of Sustainability & Impact	1.8yrs	데이터 없음	0.015% € 753.7k
Arnaud Berthe	Managing Director of Group Accounting	no data	데이터 없음	데이터 없음
Valérie Ducourty	Managing Director of Corporate Financing	no data	데이터 없음	데이터 없음
Jean-Daniel Vouille	Chief Technical Officer	no data	데이터 없음	데이터 없음
Domitille Doat-Le Bigot	Chief Digital & Information Officer	less than a year	데이터 없음	데이터 없음
Pierre Bernardin	Director & Head of Investor Relations	5.2yrs	데이터 없음	데이터 없음
Sylviane Guyonnet	Deputy CEO of EGI & Group Head of Compliance	no data	데이터 없음	데이터 없음
Florine Letort	Legal & Compliance Manager	no data	데이터 없음	데이터 없음

2.7yrs

평균 재임 기간

53.5yo

평균 연령

경험이 풍부한 관리: RF 의 관리팀은 경험 ( 2.7 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Vivianne Akriche	Employee Representative Member of the Supervisory Board & Managing Director of Mid-large buyout	5.8yrs	데이터 없음	0.016% € 828.9k
Stephane Bostyn	Employee Representative Supervisory Board Member	no data	데이터 없음	0.0074% € 376.6k
Bruno Roger	Honorary Chairman of the Supervisory Board	no data	€26.00k	데이터 없음
Jean-Pierre Richardson	Non-Voting Board Member	16.5yrs	€66.14k	0.0023% € 119.2k
Jean-Charles Decaux	Chairman of the Supervisory Board	7.4yrs	€193.33k	0.0011% € 58.3k
Victoire de Margerie	Independent Member of Supervisory Board	12.5yrs	€47.00k	0.0011% € 56.8k
Stephane Pallez	Independent Member of the Supervisory Board	11.5yrs	€78.25k	0.0023% € 118.2k
Olivier du Vignaux	Vice Chairman of Supervisory Board	20.5yrs	€103.00k	0.0012% € 61.4k
Roland du de Montsaulnin	Member of Supervisory Board	20.5yrs	€55.00k	0.0029% € 148.9k
Francoise Mercadal-Delasalles	Independent Member of the Supervisory Board	9.5yrs	€102.00k	0.0011% € 55.8k
Mathilde Lemoine	Independent Member of the Supervisory Board	2.6yrs	€32.00k	0.00035% € 17.9k
Emmanuel Russel	Member of Supervisory Board	7.4yrs	€103.14k	데이터 없음

10.5yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 이사회: RF 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 10.5 년).

Eurazeo 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Cathia Lawson-Hall Joins the Board of Eurazeo SE as Non-Executive Director

Eurazeo SE, Annual General Meeting, May 07, 2025

Eurazeo SE, Annual General Meeting, May 07, 2024

Eurazeo SE, Annual General Meeting, Apr 28, 2022

What Can We Make Of Eurazeo's (EPA:RF) CEO Compensation?

Eurazeo Appoints Christophe Bavière as Head of Investment Partners

Recent updates

What You Need To Know About The Eurazeo SE (EPA:RF) Analyst Downgrade Today

Need To Know: The Consensus Just Cut Its Eurazeo SE (EPA:RF) Estimates For 2024

Eurazeo SE (ENXTPA:RF) and management of Eres acquired an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners.

First half 2024 earnings released: €1.43 loss per share (vs €25.36 profit in 1H 2023)

Consensus revenue estimates decrease by 20%

Eurazeo SE (ENXTPA:RF) and Marlin Equity Partners, LLC agreed to acquire an unknown majority stake in Rydoo N.V. from Marlin Equity Partners, LLC.

Bridgepoint Europe VII fund managed by Bridgepoint Group plc (LSE:BPT) signed an agreement to acquire unknown majority stake in LumApps SAS from a group of shareholders for $650 million.

Consensus EPS estimates fall by 15%

Cathia Lawson-Hall Joins the Board of Eurazeo SE as Non-Executive Director

Eurazeo SE, Annual General Meeting, May 07, 2025

Upcoming dividend of €2.42 per share

Eurazeo SE (ENXTPA:RF) and management of Eres signed an agreement to acquire an unknown majority stake in Eres Gestion from IK VIII, a fund managed by IK Partners on April 22, 2024.

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

Carl Zeiss Meditec AG (XTRA:AFX) completed the acquisition of Dutch Ophthalmic Research Center (International) B.V. from Eurazeo China Acceleration Fund and Eurazeo Capital IV funds managed by Eurazeo SE (ENXTPA:RF).

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: €25.94 (vs €8.33 in FY 2022)

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €200 million worth of its shares.

If EPS Growth Is Important To You, Eurazeo (EPA:RF) Presents An Opportunity

There Is A Reason Eurazeo SE's (EPA:RF) Price Is Undemanding

Eurazeo SE, Annual General Meeting, May 07, 2024

Does Eurazeo (EPA:RF) Deserve A Spot On Your Watchlist?

Eurazeo SE (ENXTPA:RF) acquired 34% stake in BMS Group Limited from Bms Investment Holdings Limited.

Eurazeo SE to Report Fiscal Year 2023 Results on Mar 07, 2024

First half 2023 earnings released: EPS: €25.36 (vs €1.33 loss in 1H 2022)

Should You Be Adding Eurazeo (EPA:RF) To Your Watchlist Today?

New major risk - Revenue and earnings growth

Eurazeo SE to Report First Half, 2023 Results on Jul 27, 2023

Upcoming dividend of €2.20 per share at 3.3% yield

Full year 2022 earnings released: EPS: €8.33 (vs €22.17 in FY 2021)

We Ran A Stock Scan For Earnings Growth And Eurazeo (EPA:RF) Passed With Ease

Eurazeo SE (ENXTPA:RF) alongside NeoXam's founder Serge Delpla and its management team led by Florent Fabre intered into an agreement to acquire NeoXam from Bpifrance Investissement SAS and Cathay Capital Private Equity SAS.

Consensus forecasts updated

Consensus forecasts updated

An investor group led by North Castle Partners, LLC has reached an agreement to acquire an unknown majority stake in Nest New York from Eurazeo SE (ENXTPA:RF).

carsales.com Ltd (ASX:CAR) completed the acquisition of remaining 51% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Price target decreased to €89.79

Here's Why We Think Eurazeo (EPA:RF) Is Well Worth Watching

First half 2022 earnings released

Consensus forecasts updated

Macquarie Group Limited (ASX:MQG) in a consortium with British Columbia Investment Management Corporation and MEAG MUNICH ERGO Asset Management GmbH acquired Reden Solar for an enterprise value of €2.5 billion.

Eurazeo SE (ENXTPA:RF) alongside the WiiSmile's management team entered into agreement to acquire majority stake in WiiSmile SA.

Eurazeo SE to Report First Half, 2022 Results on Jul 27, 2022

Consensus forecasts updated

Eurazeo SE (ENXTPA:RF) announces an Equity Buyback for €100 million worth of its shares.

Upcoming dividend of €3.00 per share

Eurazeo SE, Annual General Meeting, Apr 28, 2022

Investor sentiment improved over the past week

Eurazeo European Real Estate II, managed by Eurazeo SE (ENXTPA:RF) acquired Six mixed-use commercial properties from Gewerbesiedlungs-Gesellschaft Mit Beschränkter Haftung.

Eurazeo SE (ENXTPA:RF) and existing management team of Cranial Technologies, Inc. signed a definitive agreement to acquire Cranial Technologies, Inc. from BPOC and existing management team.

Eurazeo SE (ENXTPA:RF) agreed to acquire Five Ayre brand hotels from El Corte Inglés, S.A. and Palladium Hotel Group.

Eurazeo SE (ENXTPA:RF) acquire 80% stake in Ikaros Solar NV from its founders and FCPR Capenergie 2, fund managed by Omnes Capital S.A.S.

Eurazeo SE (ENXTPA:RF), Cherng Family Trust and Cohesive Capital Management, L.P. acquired a controlling stake in Beekman 1802 LLC for $92 million.

Safran Enters into Exclusive Discussions to Acquire Orolia

Safran Enters Exclusive Talks to Buy Navigation Technology Company

Eurazeo SE (ENXTPA:RF) along with Arax Properties Ltd entered into an agreement to acquire Trinity Trading Estate in Sittingbourne from St. James's Place plc (LSE:STJ).

carsales.com Ltd (ASX:CAR) completed the acquisition of a 49% stake in Trader Interactive, LLC from Eurazeo SE (ENXTPA:RF).

Eurazeo in Talks over Sale of Its Stake in Seqens

Price target increased to €80.63

Montagu Private Equity LLP agreed to acquire unknown majority stake in In'Tech Medical SAS from Eurazeo SE (ENXTPA:RF).

Visa Inc. (NYSE:V) signed a definitive agreement to acquire Tink AB from SEB Venture Capital, PostePay SpA and others for €1.7 billion.

Eurazeo and Infravia Reportedly to Launch an Auction for Reden

Eurazeo SE (ENXTPA:RF), Theodore-Michel Vrangos and Laurent Charvériat entered into an agreement to acquire 49% stake in I-Tracing SAS from Keensight Capital for €165 million.

Upcoming dividend of €1.50 per share

Should Eurazeo SE (EPA:RF) Be Part Of Your Income Portfolio?

Full year 2020 earnings released: €2.26 loss per share (vs €1.59 profit in FY 2019)

Price target increased to €69.86

Eurazeo SE Announces Its Intention to Resume Distribution